NCT01569126View on ClinicalTrials.gov

A Study of LY110140 in Healthy Japanese Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

LY110140

Administered orally as capsules

DRUG

Placebo

Administered orally as capsules in the placebo arm and to maintain the blind in the 20 mg LY110140 (MD) arm

Trial Locations (1)

532-0003

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Osaka

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01569126 - A Study of LY110140 in Healthy Japanese Male Participants | Biotech Hunter | Biotech Hunter